$143 Million is the total value of Burrage Capital Management LLC's 26 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TPTX | TURNING PT THERAPEUTICS INC COM | $4,985,000 | +53.4% | 77,172 | 0.0% | 3.49% | +9.1% | |
RGNX | REGENXBIO INC COM | $4,235,000 | +19.7% | 115,000 | 0.0% | 2.96% | -14.9% | |
AVRO | AVROBIO INC COM | $3,942,000 | +20.4% | 225,900 | 0.0% | 2.76% | -14.3% | |
ADVM | ADVERUM BIOTECHNOLOGIES INC COM | $3,258,000 | +109.0% | 156,012 | 0.0% | 2.28% | +48.6% | |
APLS | APELLIS PHARMACEUTICALS INC COM | $2,432,000 | +19.3% | 74,452 | 0.0% | 1.70% | -15.2% | |
ZGNX | ZOGENIX INC COM NEW | $1,891,000 | +14.5% | 70,000 | 0.0% | 1.32% | -18.6% | |
ADRO | ADURO BIOTECH INC COM | $314,000 | -13.5% | 135,898 | 0.0% | 0.22% | -38.4% | |
AUTL | AUTOLUS THERAPEUTICS LTD SPONSORED ADSspon ads | $241,000 | +186.9% | 15,006 | 0.0% | 0.17% | +103.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EPIZYME INC COM | 7 | Q2 2021 | 15.9% |
NeoGenomics Inc | 7 | Q2 2021 | 8.7% |
OrthoPediatrics Corp | 7 | Q2 2021 | 7.3% |
Y-MABS THERAPEUTICS INC COM | 7 | Q2 2021 | 4.3% |
CRINETICS PHARMACEUTICALS INC COM | 7 | Q2 2021 | 5.6% |
G1 THERAPEUTICS INC COM | 7 | Q2 2021 | 7.3% |
PTC THERAPEUTICS INC COM | 6 | Q1 2021 | 8.0% |
CYTOKINETICS INC COM NEW | 6 | Q2 2021 | 4.9% |
TURNING PT THERAPEUTICS INC COM | 6 | Q2 2021 | 6.7% |
APELLIS PHARMACEUTICALS INC COM | 6 | Q1 2021 | 3.5% |
View Burrage Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Protalix BioTherapeutics, Inc.Sold out | July 30, 2021 | 0 | 0.0% |
IVERIC bio, Inc. | February 14, 2020 | 10 | 3.4% |
View Burrage Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
SC 13G/A | 2021-07-30 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-12 |
SC 13G | 2021-02-12 |
13F-HR | 2020-11-13 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-14 |
View Burrage Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.